|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/64 | (2017.01) |
| A61P 21/00 | (2006.01) |
| (11) | Number of the document | 4122497 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22180767.0 |
| Date of filing the European patent application | 2017-12-14 | |
| (97) | Date of publication of the European application | 2023-01-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-10 |
| (46) | Date of publication of the claims translation | 2024-06-10 |
| (30) | Number | Date | Country code |
| 201662436199 P | 2016-12-19 | US | |
| 201762443481 P | 2017-01-06 | US | |
| 201762479177 P | 2017-03-30 | US | |
| 201762562119 P | 2017-09-22 | US |
| (72) |
PASSINI, Marco, A. , US
HANSON, Gunnar, J. , US
|
| (73) |
Sarepta Therapeutics, Inc. ,
215 First Street, Suite 415, Cambridge, MA 02142,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Egzonus praleidžiantys oligomerų konjugatai, skirti raumenų distrofijai gydyti |
| EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY |
| Payment date | Validity (years) | Amount | |
| 2025-11-24 | 9 | 208.00 EUR |
| 2026-12-14 |